Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMST01010014 | 4β-hydroxy-cholesterol | Lipid-depleted/compactin | 0.0 | BCD100322A02 | 3.52 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | Lipid-depleted/compactin | 0.5 | BCD100322A05 | 4.88 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | Lipid-depleted/compactin | 1.0 | BCD100322A09 | 4.85 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | Lipid-depleted/compactin | 2.0 | BCD100322A13 | 3.55 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | Lipid-depleted/compactin | 4.0 | BCD100322A17 | 3.63 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | Lipid-depleted/compactin | 8.0 | BCD100322A21 | 5.02 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | Lipid-depleted/compactin | 12.0 | BCD100322A25 | 6.14 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | Lipid-depleted/compactin | 24.0 | BCD100322A29 | 5.22 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | C | 0.0 | BCD100322A01 | 5.22 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | C | 0.5 | BCD100322A03 | 3 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | C | 1.0 | BCD100322A07 | 4.9 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | C | 2.0 | BCD100322A11 | 5.63 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | C | 4.0 | BCD100322A15 | 6.79 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | C | 8.0 | BCD100322A19 | 9.69 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | C | 12.0 | BCD100322A23 | 8.55 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | C | 24.0 | BCD100322A27 | 9.76 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A06 | 4.07 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A10 | 4.78 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A14 | 3.08 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A18 | 2.94 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A22 | 5.11 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A26 | 5.83 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A30 | 6.36 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | 25OH-Chol | 0.5 | BCD100322A04 | 6.29 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | 25OH-Chol | 1.0 | BCD100322A08 | 5.86 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | 25OH-Chol | 2.0 | BCD100322A12 | 8.05 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | 25OH-Chol | 4.0 | BCD100322A16 | 6.05 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | 25OH-Chol | 8.0 | BCD100322A20 | 6.26 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | 25OH-Chol | 12.0 | BCD100322A24 | 10.7 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | 25OH-Chol | 24.0 | BCD100322A28 | 8.94 | pmol/sample |